Literature DB >> 28091864

Letter to the Editor: Intranasal Glucagon for Hypoglycemia.

Antonio E Pontiroli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28091864     DOI： 10.1007/s11892-017-0833-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  6 in total

1.  Intranasal glucagon raises blood glucose concentrations in healthy volunteers.

Authors:  A E Pontiroli; M Alberetto; G Pozza
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-13

2.  Intranasal glucagon as remedy for hypoglycemia. Studies in healthy subjects and type I diabetic patients.

Authors:  A E Pontiroli; A Calderara; E Pajetta; M Alberetto; G Pozza
Journal:  Diabetes Care       Date:  1989-10       Impact factor: 19.112

3.  Nasal administration of glucagon and human calcitonin to healthy subjects: a comparison of powders and spray solutions and of different enhancing agents.

Authors:  A E Pontiroli; M Alberetto; A Calderara; E Pajetta; G Pozza
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 4.  Management of Hypoglycemia in Children and Adolescents with Type 1 Diabetes Mellitus.

Authors:  Dayna E McGill; Lynne L Levitsky
Journal:  Curr Diab Rep       Date:  2016-09       Impact factor: 4.810

5.  Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.

Authors:  Michael R Rickels; Katrina J Ruedy; Nicole C Foster; Claude A Piché; Hélène Dulude; Jennifer L Sherr; William V Tamborlane; Kathleen E Bethin; Linda A DiMeglio; R Paul Wadwa; Andrew J Ahmann; Michael J Haller; Brandon M Nathan; Santica M Marcovina; Emmanouil Rampakakis; Linyan Meng; Roy W Beck
Journal:  Diabetes Care       Date:  2015-12-17       Impact factor: 19.112

6.  Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.

Authors:  Jennifer L Sherr; Katrina J Ruedy; Nicole C Foster; Claude A Piché; Hélène Dulude; Michael R Rickels; William V Tamborlane; Kathleen E Bethin; Linda A DiMeglio; Larry A Fox; R Paul Wadwa; Desmond A Schatz; Brandon M Nathan; Santica M Marcovina; Emmanouil Rampakakis; Linyan Meng; Roy W Beck
Journal:  Diabetes Care       Date:  2016-02-16       Impact factor: 19.112
  6 in total
  1 in total

Review 1.  CRISPR/Cas System Toward the Development of Next-Generation Recombinant Vaccines: Current Scenario and Future Prospects.

Authors:  Muhammad Naeem; Hanoof Fahd Alkhodairy; Iqra Ashraf; Amjad Bajes Khalil
Journal:  Arab J Sci Eng       Date:  2022-09-23       Impact factor: 2.807
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.